Weight gain composition in preterm infants with dual energy X-ray absorptiometry

C Pieltain1, M De Curtis, P Gérard

  • 1Department of Pediatrics, Division of Neonatology, University of Liège, CHR Citadelle, B-4000 Liège, Belgium,

Pediatric Research
|January 3, 2001
PubMed

Insights

Preterm infants fed formula showed greater weight gain, fat mass, and bone development compared to those fed fortified human milk. Dual energy x-ray absorptiometry effectively evaluates dietary impacts on infant body composition.

Area of Science:

  • Neonatal Nutrition
  • Pediatric Body Composition Analysis

Background:

  • Preterm infants (<1750g) require specialized nutrition for optimal growth.
  • Assessing body composition changes is crucial for evaluating nutritional interventions in vulnerable infants.

Purpose of the Study:

  • To compare whole body composition and weight gain in preterm infants fed fortified human milk versus preterm formula.
  • To determine the minimal detectable changes in body composition for longitudinal studies and dietary intervention comparisons.

Main Methods:

  • Dual energy x-ray absorptiometry (DXA) was used to measure body composition in 54 preterm infants at two time points.
  • Infants were divided into two groups: fortified human milk (n=20) and preterm formula (n=34).
  • Weight gain composition was calculated from the difference between measurements.

Main Results:

  • Formula-fed infants exhibited significantly greater weight gain, fat mass deposition, bone mineral content gain, and bone area increase.
  • Initial body composition was similar, but significant differences emerged by discharge.
  • Specific minimal detectable changes for lean body mass, fat mass, and bone mineral content were established for different study designs.

Conclusions:

  • Dual energy x-ray absorptiometry is a valuable tool for assessing dietary intervention effects on preterm infant body composition.
  • Preterm formula supports greater accretion of fat mass and bone mineral compared to fortified human milk in this cohort.
  • DXA enables precise quantification of growth parameters critical for optimizing preterm infant nutrition.

Related Concept Videos

Physical Growth During Infancy and Toddlerhood01:18

Physical Growth During Infancy and Toddlerhood

Physical growth is especially rapid during the first three years of life, with the greatest rate in the first few months after birth. Although children continue to gain height and weight throughout infancy and toddlerhood, the rate of growth gradually slows during the second and third years. At most ages, boys are typically slightly taller and heavier than girls, reflecting a common pattern of early physical development.Changes in Body ProportionsAs infants become toddlers, their body...
Energy Balance01:19

Energy Balance

The human body gets energy from the three macronutrients: carbohydrates, proteins, and fats. Energy is released when the chemical bonds in the organic compounds present in the food are broken down. The energy content of food is measured in kilocalories (kcal), defined as the amount of heat required to raise the temperature of one kilogram of water by one degree Celsius. This value is determined by measuring the temperature change of the water surrounding a calorimeter after the complete...
X-ray Imaging01:24

X-ray Imaging

German physicist Wilhelm Röntgen (1845–1923) was experimenting with electrical current when he discovered that a mysterious and invisible "ray" would pass through his flesh but leave an outline of his bones on a screen coated with a metal compound. In 1895, Röntgen made the first durable record of the internal parts of a living human: an "X-ray" image (as it came to be called) of his wife’s hand. Scientists worldwide quickly began their own experiments with X-rays, and by 1900, X-ray was widely...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...